Triglyceride Care Maryland
BALANCE Study Findings: Olezarsen’s Potential in Treating Familial Chylomicronemia Syndrome
Olezarsen is an investigational drug that tackles triglycerides by blocking the production of apolipoprotein C-III (apoC3). ApoC3 normally hinders the liver’s ability to remove triglycerides from the blood. By reducing apoC3, Olezarsen allows the liver to work more effectively, lowering triglyceride levels. This can significantly reduce the risk of pancreatitis, a dangerous condition caused by high triglyceride levels in the blood.
Published
Categorized as Dr. Tashko’s Key Clinical Trials, Drug Information, Genetics, Lipid Health, Pancreas Health, Triglycerides